Serum concentrations of remnant‐like particles in hypothyroid patients before and after thyroxine replacement

objectives  Remnant‐like particles (RLPs) reflect chylomicron remnants and very‐low‐density lipoprotein remnants, which are most likely to be atherogenic particles. To investigate the effect of thyroxine replacement on the metabolism of RLPs in hypothyroidism, we measured serum concentrations of RLPs during an oral fat‐loading test in patients with hypothyroidism before and after thyroxine replacement.

[1]  K. Nakajima,et al.  Postprandial remnant-like lipoproteins in hypertriglyceridemia. , 2001, The Journal of clinical endocrinology and metabolism.

[2]  H. Koppeschaar,et al.  Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. , 2000, The Journal of clinical endocrinology and metabolism.

[3]  T. McLaughlin,et al.  Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. , 1999, The Journal of clinical endocrinology and metabolism.

[4]  N. Stern,et al.  Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[5]  Hirofumiyasue,et al.  Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease , 1999 .

[6]  H Yasue,et al.  Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. , 1999, Circulation.

[7]  T. Taniguchi,et al.  Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. , 1999, Diabetes care.

[8]  K. Nakajima,et al.  Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[9]  Y. Yazaki,et al.  Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Hofman,et al.  Postprandial Triglyceride Response in Young Adult Men and Familial Risk for Coronary Atherosclerosis , 1994, Annals of Internal Medicine.

[11]  J. Taylor,et al.  Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Nakajima,et al.  Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[13]  M. Taskinen,et al.  Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism. , 1993, The Journal of clinical endocrinology and metabolism.

[14]  T. D. de Bruin,et al.  Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. , 1993, The Journal of clinical endocrinology and metabolism.

[15]  R. Havel,et al.  Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. , 1992, Journal of lipid research.

[16]  A. Hofman,et al.  Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[17]  A. Takagi,et al.  Purification and characterization of lipoprotein lipase and hepatic triglyceride lipase from human postheparin plasma: production of monospecific antibody to the individual lipase. , 1989, Biochimica et biophysica acta.

[18]  M. Taskinen,et al.  Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. , 1988, The Journal of clinical endocrinology and metabolism.

[19]  J. Ellsworth,et al.  Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. , 1987, The Journal of biological chemistry.

[20]  J. Little,et al.  Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. , 1982, Atherosclerosis.

[21]  P. Nilsson-ehle,et al.  Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism , 1982, European journal of clinical investigation.

[22]  H. Lithell,et al.  Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein‐lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy , 1981, European journal of clinical investigation.

[23]  S. Grundy,et al.  Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. , 1981, Journal of lipid research.

[24]  C. Florén,et al.  Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. , 1981, Biochimica et biophysica acta.

[25]  D. B. Zilversmit.  Atherogenesis: a postprandial phenomenon. , 1979, Circulation.

[26]  N. Farid,et al.  Serum lipids in hypothyroidism--a re-evaluation. , 1978, The Journal of clinical endocrinology and metabolism.

[27]  A. Goldberg,et al.  Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism. , 1976, The Journal of clinical endocrinology and metabolism.

[28]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[29]  E. Nikkilä,et al.  Plasma triglyceride metabolism in thyroid disease. , 1972, The Journal of clinical investigation.

[30]  F. R. Smith,et al.  The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. , 1971, The Journal of clinical investigation.